For much of this draft cycle, garrett nussmeier looked like a player who might force his way into the first-round conversation. Instead, his path has turned into one of the draft’s sharpest reversals. After a rough 2025 season at LSU and medical tests that revealed a cyst on his spine, his name now sits in a different kind of conversation: not whether he can be a headline pick, but whether a team can find value in the slide.
Why Garrett Nussmeier now looks like a value play
The biggest reason garrett nussmeier remains relevant is that the league’s quarterback market has already moved quickly. The first round has already seen multiple teams address the position, and that changes the pressure points for the rest of the draft. When the top demand is satisfied early, the quarterbacks left behind are often judged less on reputation and more on fit, medical confidence, and patience.
That is the lane Nussmeier now occupies. A year ago, he was being viewed as a quarterback who could compete near the top of the class. In this draft environment, he is being framed as a distressed asset: not erased from the board, but re-priced because of how 2025 unfolded. For a team that missed on the early run, that can create opportunity if it believes the previous season says more about circumstances than ceiling.
What changed after LSU’s 2025 season?
The decline in Nussmeier’s profile is tied to two facts that cannot be separated. First, LSU’s offense never found consistent rhythm. Second, his production dropped with it. He averaged under seven yards per attempt, finished with 12 touchdowns and five interceptions in nine games, and was eventually shut down for the season. That is the kind of statistical downturn that changes draft boards quickly, especially when it follows months of first-round buzz.
But the medical revelation adds another layer. Testing at the combine found a cyst on his spine, and the issue is believed to have been the root cause of persistent oblique pain that disrupted his season. That matters because draft rooms often sort quarterback risk into two categories: performance risk and medical risk. Nussmeier now carries both, even though the reported outlook leaves room for recovery and a short absence if a minimally invasive procedure is pursued.
How the medical update changes the draft lens
The cyst on Nussmeier’s spine does not automatically define his future, but it does alter how teams may interpret the season that damaged his stock. If the pain was driving discomfort rather than simply coinciding with poor play, then his 2025 tape may be judged with more caution than condemnation. That distinction is critical. Draft decisions at quarterback often hinge on whether a team sees a temporary setback or a deeper structural concern.
This is where the phrase “buy the dip” becomes more than a market metaphor. If teams believe the dip was magnified by an injury issue that can be managed, Nussmeier could become one of the draft’s better value bets. If they believe the inconsistency reflects a more permanent limit, the slide could continue. The same facts can support either reading, which is why his case remains one of the draft’s more closely watched.
Expert views and the quarterback market
Evaluators inside the draft conversation have not hidden the contrast between Nussmeier’s pre-2025 standing and his current position. One assessment placed him among the very top players in the class before the season, while another noted that his rough LSU year may ultimately serve him by sending him to a better situation later in the draft. That is the central analytical tension around garrett nussmeier: a decline in status does not always mean a decline in long-term value.
The broader quarterback picture also matters. With Fernando Mendoza gone at No. 1 and Ty Simpson positioned near the top of the class, the remaining quarterbacks are being sorted less by urgency and more by willingness to wait. In that environment, a player with pedigree, prior production, and a clearer explanation for his 2025 dip can still attract serious attention.
Regional and national ripple effects
For LSU, the story is not just about one player’s draft slot. It also reflects how quickly a season can reshape perception around a program’s quarterback pipeline. For the NFL, the ripple effect is more direct: every quarterback taken early compresses the market for the rest, and that can push a player like Nussmeier into a round where developmental patience becomes part of the pitch.
The wider lesson is simple. In a class with fewer obvious quarterback debates than usual, the medical file and the game tape matter even more. That is why garrett nussmeier may still matter to teams that need a future option, even if he no longer carries the glow of a first-round lock. The question now is whether one franchise sees enough upside to treat the slide as a chance rather than a warning.
When the board settles, will garrett nussmeier be remembered as a cautionary tale about risk, or as the quarterback a patient team found before the market corrected?
